advertisement

Topcon

Oogi S 15

Showing records 1 to 15 | Display all abstracts from Oogi S

106950 Efficacy and safety of a fixed combination of 1% brinzolamide and 0.1% brimonidine as treatment for glaucoma: a retrospective study focusing on the number of ingredients
Aoki R
BMJ open ophthalmology 2022; 7:
106376 Effect of idiopathic epiretinal membrane on macular ganglion cell complex measurement in eyes with glaucoma
Nakakura S
Frontiers in medicine 2022; 9: 972962
106378 Case report: Findings of automated perimetry during a migraine episode in a patient with glaucoma
Nakakura S; Oogi S
Frontiers in medicine 2022; 9: 950148
106950 Efficacy and safety of a fixed combination of 1% brinzolamide and 0.1% brimonidine as treatment for glaucoma: a retrospective study focusing on the number of ingredients
Terao E
BMJ open ophthalmology 2022; 7:
106376 Effect of idiopathic epiretinal membrane on macular ganglion cell complex measurement in eyes with glaucoma
Asaoka R; Oogi S
Frontiers in medicine 2022; 9: 972962
106950 Efficacy and safety of a fixed combination of 1% brinzolamide and 0.1% brimonidine as treatment for glaucoma: a retrospective study focusing on the number of ingredients
Dote S
BMJ open ophthalmology 2022; 7:
106378 Case report: Findings of automated perimetry during a migraine episode in a patient with glaucoma
Tanoue A
Frontiers in medicine 2022; 9: 950148
106950 Efficacy and safety of a fixed combination of 1% brinzolamide and 0.1% brimonidine as treatment for glaucoma: a retrospective study focusing on the number of ingredients
Shiraishi M
BMJ open ophthalmology 2022; 7:
106376 Effect of idiopathic epiretinal membrane on macular ganglion cell complex measurement in eyes with glaucoma
Aoki R
Frontiers in medicine 2022; 9: 972962
106378 Case report: Findings of automated perimetry during a migraine episode in a patient with glaucoma
Miyoshi T
Frontiers in medicine 2022; 9: 950148
106950 Efficacy and safety of a fixed combination of 1% brinzolamide and 0.1% brimonidine as treatment for glaucoma: a retrospective study focusing on the number of ingredients
Oogi S
BMJ open ophthalmology 2022; 7:
106376 Effect of idiopathic epiretinal membrane on macular ganglion cell complex measurement in eyes with glaucoma
Terao E; Ueda K
Frontiers in medicine 2022; 9: 972962
106950 Efficacy and safety of a fixed combination of 1% brinzolamide and 0.1% brimonidine as treatment for glaucoma: a retrospective study focusing on the number of ingredients
Ueda K
BMJ open ophthalmology 2022; 7:
106376 Effect of idiopathic epiretinal membrane on macular ganglion cell complex measurement in eyes with glaucoma
Kiuchi Y
Frontiers in medicine 2022; 9: 972962
106950 Efficacy and safety of a fixed combination of 1% brinzolamide and 0.1% brimonidine as treatment for glaucoma: a retrospective study focusing on the number of ingredients
Kimura Y; Nagata Y; Nakakura S
BMJ open ophthalmology 2022; 7:

Issue 23-3

Change Issue


advertisement

Nidek